Fitbit Receives Army Award to Help Accelerate its COVID-19 Wearable Detection Technology - Seite 2
“The combination of Feinstein Institutes’ research expertise, Northwell’s COVID-19 testing capabilities and Fitbit’s promising algorithm in development, presents a unique opportunity to accelerate early detection of COVID-19, particularly for our frontline health care workers,” said Karina Davidson, PhD, senior vice president at the Feinstein Institutes. “Based on our learnings, we aim to work together to advise other large-scale health systems on this approach to minimizing the spread of COVID-19.”
This prospective study builds upon Fitbit’s work in COVID-19 research, which includes its collaborative research consortium with The Scripps Research Institute and Stanford Medicine that launched earlier this year. As part of that effort, Fitbit is conducting a retrospective study to determine whether it can develop an algorithm to detect COVID-19 before symptoms start. To date, the study has over 187,500 enrolled participants in the U.S. and Canada, including more than 2,700 confirmed positive cases of COVID-19. Early findings from that study show the Fitbit algorithm can detect nearly 50% of COVID-19 cases one day before participants report the onset of symptoms with 70% specificity. This is important because people can transmit the virus before they realize they have symptoms or when they have no symptoms at all. This study reinforces that breathing rate, resting heart rate, and heart rate variability (HRV) are all useful metrics for indicating onset of illness and are best tracked at night, when the body is at rest.
“The Department of Defense seeks rapid, accurate wearable solutions to identify and isolate pre-symptomatic COVID-19 cases and help track and prevent the spread of the virus. To address this need, our proposal selection process sought mature solutions that could be rapidly and widely deployed,” said Commander Christopher Steele, Director of the Military Operational Medicine Research Program at USAMRDC. “Wearable technologies, valuable data metrics and potentially rapid scaling solutions for broad availability, create ideal conditions for military and industry partnerships in the consumer wearables space.”
Early detection is critical, and Fitbit hopes to bring wearable illness detection capabilities to its users as soon as possible. Fitbit will engage with the appropriate regulators to determine the best path forward to bring these features to market.
About Fitbit, Inc. (NYSE: FIT)
Fitbit helps people lead healthier, more active lives by empowering them with data, inspiration and guidance to reach their goals. Fitbit designs products and experiences that track and provide motivation for everyday health and fitness. Fitbit’s diverse line of innovative and popular products include Fitbit Sense, the Fitbit Versa family of smartwatches, Fitbit Charge 4, Fitbit Inspire 2, and Fitbit Ace 2 activity trackers, and Fitbit Aria Air smart scale. Fitbit products are carried in approximately 39,000 retail stores and in 100+ countries around the globe. The Fitbit platform delivers personalized experiences, insights and guidance through leading software and interactive tools, including the Fitbit and Fitbit Coach apps, and Fitbit OS for smartwatches. Fitbit’s paid subscription service, Fitbit Premium, provides advanced analytics and actionable guidance in the Fitbit app to help you reach your health and fitness goals. Fitbit Premium + Health Coaching provides one-on-one virtual coaching with expert health coaches and personalized plans based on your Fitbit data. Fitbit Health Solutions develops health and wellness solutions designed to help increase engagement, improve health outcomes, and drive a positive return for employers, health plans and health systems. Fitbit and the Fitbit logo are trademarks or registered trademarks of Fitbit, Inc. in the U.S. and other countries. Additional Fitbit trademarks can be found www.fitbit.com/legal/trademark-list. Third-party trademarks are the property of their respective owners.